BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2825817)

  • 1. Paradoxical differences in the receptor binding of two new antimineralocorticoids.
    Agarwal MK; Kalimi M
    Biochim Biophys Acta; 1988 Jan; 964(1):105-12. PubMed ID: 2825817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mechanisms for the receptor mediated antimineralocorticoid action of two new spirolactone derivatives.
    Agarwal MK; Kalimi M
    Biochem Biophys Res Commun; 1988 Jan; 150(1):449-55. PubMed ID: 2827677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the mineralocorticoid receptor in rat heart with the aid of two new spirolactone derivatives.
    Agarwal MK; Kalimi M
    Biochem Med Metab Biol; 1989 Feb; 41(1):36-45. PubMed ID: 2540779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of mineralocorticoid agonist and antagonist specific receptors from rat kidney.
    Agarwal MK; Kalimi M
    Biochem Biophys Res Commun; 1987 Feb; 143(1):398-402. PubMed ID: 3030321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties and distribution of binding sites for the mineralocorticoid receptor antagonist [3H]ZK 91587 in brain.
    Grillo C; Vallee S; McEwen BS; De Nicola AF
    J Steroid Biochem; 1990 Jan; 35(1):11-5. PubMed ID: 2155344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics of mineralocorticoid and glucocorticoid receptors in dog brain and pituitary.
    Reul JM; de Kloet ER; van Sluijs FJ; Rijnberk A; Rothuizen J
    Endocrinology; 1990 Aug; 127(2):907-15. PubMed ID: 2164924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimineralocorticoids.
    Agarwal MK; Lazar G
    Ren Physiol Biochem; 1991; 14(6):217-23. PubMed ID: 1720252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for an antagonist specific receptor that does not bind mineralocorticoid agonists.
    Lazar G; Agarwal MK
    Biochem Biophys Res Commun; 1986 Jan; 134(1):261-5. PubMed ID: 3004430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship of new steroidal aldosterone antagonists. Comparison of the affinity for mineralocorticoid receptors in vitro and the antialdosterone activity in vivo.
    Wambach G; Casals-Stenzel J
    Biochem Pharmacol; 1983 May; 32(9):1479-85. PubMed ID: 6222738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of spironolactone binding sites distinct from aldosterone receptors in rat kidney homogenates.
    Luzzani F; Glässer A
    Biochem Pharmacol; 1984 Jul; 33(14):2277-81. PubMed ID: 6235813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RU-26988--a new tool for the study of the mineralocorticoid receptor.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    Endocrinology; 1983 Sep; 113(3):1004-9. PubMed ID: 6307658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation and nuclear translocation of brain type L corticosteroid receptors complexed with the mineralocorticoid antagonist ZK 91587, aldosterone or dexamethasone.
    Grillo C; Vallee SM; Piroli G; McEwen BS; De Nicola AF
    J Steroid Biochem Mol Biol; 1992 Jun; 42(5):515-20. PubMed ID: 1616881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships for agonistic and antagonistic mineralocorticoids.
    Genard P; Palem-Vliers P
    J Steroid Biochem; 1980 Nov; 13(11):1299-305. PubMed ID: 6256585
    [No Abstract]   [Full Text] [Related]  

  • 14. Mineralocorticoid receptors in rat anterior pituitary: toward a redefinition of "mineralocorticoid hormone".
    Krozowski Z; Funder JW
    Endocrinology; 1981 Oct; 109(4):1221-4. PubMed ID: 6269837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor.
    Rafestin-Oblin ME; Lombes M; Couette B; Baulieu EE
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):815-21. PubMed ID: 1314085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mineralocorticoid receptor ligands: biochemical, pharmacological, and clinical aspects.
    Sutanto W; de Kloet ER
    Med Res Rev; 1991 Nov; 11(6):617-39. PubMed ID: 1662327
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity.
    Krozowski ZS; Funder JW
    Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6056-60. PubMed ID: 6310613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid and renal receptor binding activity of 21-deoxyaldosterone.
    Koshida H; Miyamori I; Soma R; Matsubara T; Ikeda M; Takeda R; Nakamura S; Kiuchi F; Tsuda Y
    Endocrinology; 1990 Mar; 126(3):1410-5. PubMed ID: 2155101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptors in the rat lung.
    Krozowski Z; Funder JW
    Endocrinology; 1981 Dec; 109(6):1811-3. PubMed ID: 6273117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
    Okamoto M; Momoi K; Yamano T; Nakamura M; Odaguchi K; Shimizu T; Okada T; Terasawa T
    Biochem Int; 1983 Dec; 7(6):687-94. PubMed ID: 6237653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.